Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 20/20 | 0.67 |
| ▸ | CNR1 | P21554 | 13/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5613165 | 0.85 | CNR2 (0.74) | CNR2CNR1 | |
| SCHEMBL19908351 | 0.85 | CNR2 (0.51) | CNR2CNR1 | |
| SCHEMBL12981405 | 0.85 | TSHR (0.50) | CNR2CNR1 | |
| SCHEMBL12014970 | 0.82 | CNR2 (0.59) | CNR2CNR1 | |
| SCHEMBL1718279 | 0.82 | CNR2 (0.56) | CNR2CNR1 | |
| SCHEMBL22175881 | 0.82 | CNR2 (0.56) | CNR2CNR1 | |
| SCHEMBL11543848 | 0.82 | CNR2 (0.56) | CNR2CNR1 | |
| SCHEMBL14732701 | 0.82 | CNR2 (0.56) | CNR2CNR1 | |
| SCHEMBL988783 | 0.82 | CNR2 (0.56) | CNR2CNR1 | |
| SCHEMBL18671 | 0.82 | ESR1 (0.60) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2520570-A1 | AMINOPYRIDINE COMPOUND | Ube Industries, Ltd. (JP) | 2012-11-07 | — | — | EP | disclosed |
| US-20120259123-A1 | AMINOPYRIDINE COMPOUND | UBE INDUSTRIES, LTD. (JP) | 2012-10-11 | — | — | US | disclosed |
| CN-102666490-A | Aminopyridine compound | UBE INDUSTRIES | 2012-09-12 | — | — | CN | disclosed |
| EP-0659738-B1 | N-(Carbonyl, carbonimidoyl, carbonothioyl) sulfonamide charge control agents and toners and developers | EASTMAN KODAK CO (US) | 1997-09-10 | — | — | EP | disclosed |
| US-5616797-A | USED IN ELECTROPHOTOGRAPHY | EASTMAN KODAK COMPANY (US) | 1997-04-01 | — | — | US | disclosed |
| EP-0659738-A1 | N-(Carbonyl, carbonimidoyl, carbonothioyl) sulfonamide charge control agents and toners and developers | EASTMAN KODAK COMPANY (US) | 1995-06-28 | — | — | EP | disclosed |
| US-5405727-A | Electrophotography | EASTMAN KODAK COMPANY (US) | 1995-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120259123-A1 | AMINOPYRIDINE COMPOUND | PTGIS, QDPR, PTGIR | CNR2 613/4885CNR1 897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.